Growth hormone therapy and scoliosis in patients with Prader–Willi syndrome
- 12 June 2006
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 140A (15), 1623-1627
- https://doi.org/10.1002/ajmg.a.31295
Abstract
Growth hormone (GH) therapy for short stature in patients with Prader–Willi syndrome (PWS) has started worldwide, and various favorable effects have been reported. However, the possibility of progression of scoliosis arises as a new problem of the GH therapy. In this study, we analyzed whether 72 patients who have been followed up in our hospital have such a problem. They included 46 males and 26 females (41 patients with the GH therapy and 31 without it) aged from one to 49 years. Consequently, 33 (45.8%) of 72 patients had scoliosis with the Cobb angle of >10 degrees. Twenty (48.8%) of forty‐one patients who received a GH therapy and 13 (41.9%) of 31 patients without the therapy had scoliosis, the frequency of scoliosis between the two groups showing no statistical difference (P = 0.56). Height velocity of scoliotic and non‐scoliotic patients during the first year of the therapy was 8.59 ± 1.92 and 10.70 ± 2.54 cm, respectively, showing a significant difference (P < 0.001). This shows that accelerated height velocity may not induce scoliosis. Comparison of starting age of a GH treatment revealed that non‐scoliotic patients received the therapy earlier than scoliotic patients (P = 0.021). Among 20 scoliotic patients who received the GH therapy, the degree of scoliosis progressed during the therapy in six patients, improved in three and fluctuated in one. Many patients showed progression of scoliosis with age irrespective of the use of GH, and some patients improved their scoliosis during the GH therapy. These findings showed that a GH therapy increases height velocity of PWS patients but does not necessarily develop scoliosis, and early start of the therapy may not be an exacerbating factor of scoliosis.Keywords
This publication has 19 references indexed in Scilit:
- Cause of sudden, unexpected death of Prader–Willi syndrome patients with or without growth hormone treatmentAmerican Journal of Medical Genetics Part A, 2005
- Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone TreatmentHormone Research in Paediatrics, 2002
- Safety of human growth hormone therapy: Current topicsThe Journal of Pediatrics, 1996
- Growth Hormone Secretion and Effects of Growth Hormone Therapy on Growth Velocity and Weight Gain in Children with Prader-Willi SyndromeJournal of Pediatric Endocrinology and Metabolism, 1996
- Adverse Events During Growth Hormone TherapyJournal of Pediatric Endocrinology and Metabolism, 1995
- Adolescent idiopathic scoliosisThe Lancet, 1994
- Age- and sex-specific prevalence of scoliosis and the value of school screening programs.American Journal of Public Health, 1985
- Progression of a Structural Scoliosis During Treatment with Growth Hormone:A Case ReportActa Orthopaedica, 1978
- GROWTH HORMONE AND SOMATOMEDIN A IN GIRLS WITH ADOLESCENT IDIOPATHIC SCOLIOSISActa Paediatrica, 1976